Establishment of an Early Prediction Model for Severe Fever With Thrombocytopenia Syndrome-Associated Encephalitis
- PMID: 39660909
- PMCID: PMC11633050
- DOI: 10.1002/iid3.70096
Establishment of an Early Prediction Model for Severe Fever With Thrombocytopenia Syndrome-Associated Encephalitis
Abstract
Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease primarily transmitted by ticks. The development of encephalitis in SFTS patients significantly increases the risk of adverse outcomes. However, the understanding of SFTS-associated encephalitis (SFTSAE) is still limited. This study aimed to identify the clinical characteristics of SFTSAE and develop a predictive model for early detection.
Methods: We retrospectively collected data from 220 SFTS patients admitted to Nanjing Drum Tower Hospital between May 2019 and January 2024. The patients were first randomly divided into a training set (154 people, 70%) and a validation set (66 people, 30%). The patients in the training set were divided into SFTSAE and non-SFTSAE groups according to the presence of encephalitis. A prediction model was constructed using the training set: important clinical parameters were selected using univariate logistic regression, and then multivariate logistic regression was performed to determine the independent risk factors for SFTSAE. A prediction model was constructed using these independent risk factors. Finally, the validation set was used to verify the predictive ability of the model.
Results: Age, C-reactive protein, d-dimer, and viral load were independent risk factors for SFTSAE (p < 0.05). A nomogram containing these four indicators was constructed, and the predictive performance of the nomogram was evaluated using the ROC curve. The AUC of the model was 0.846 (95% confidence interval [CI]: 0.770-0.921), which had good predictive ability for SFTSAE.
Conclusion: Conclusion: The overall mortality rate of SFTS patients was 17.53%, and the mortality rate of encephalitis patients was 50%. Old age, high C-reactive protein, elevated d-dimer, and high viral load were independent risk factors for SFTSAE. The nomogram constructed based on these four indicators had good predictive ability and could be used as an evaluation tool for clinical treatment.
Keywords: encephalopathy; risk factor; score model; severe fever with thrombocytopenia syndrome.
© 2024 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Analysis of the risk factors and prognosis for severe fever with thrombocytopenia syndrome associated encephalopathy.J Infect Chemother. 2023 May;29(5):464-468. doi: 10.1016/j.jiac.2023.01.014. Epub 2023 Jan 24. J Infect Chemother. 2023. PMID: 36702204
-
Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study.BMC Infect Dis. 2021 Sep 3;21(1):904. doi: 10.1186/s12879-021-06627-1. BMC Infect Dis. 2021. PMID: 34479504 Free PMC article.
-
Construction and validation of a dynamic nomogram using Lasso-logistic regression for predicting the severity of severe fever with thrombocytopenia syndrome patients at admission.BMC Infect Dis. 2024 Sep 18;24(1):996. doi: 10.1186/s12879-024-09867-z. BMC Infect Dis. 2024. PMID: 39294596 Free PMC article.
-
Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes.BMC Infect Dis. 2020 Aug 5;20(1):575. doi: 10.1186/s12879-020-05303-0. BMC Infect Dis. 2020. PMID: 32758175 Free PMC article.
-
Clinical Update of Severe Fever with Thrombocytopenia Syndrome.Viruses. 2021 Jun 23;13(7):1213. doi: 10.3390/v13071213. Viruses. 2021. PMID: 34201811 Free PMC article. Review.
References
-
- Liu Q., He B., Huang S.‐Y., Wei F., and Zhu X.‐Q., “Severe Fever With Thrombocytopenia Syndrome, an Emerging Tick‐Borne Zoonosis,” Lancet Infectious Diseases 14, no. 8 (2014): 763–772. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials